iBio (IBIO) FCF Margin Growth (5y) (2016 - 2025)
iBio (IBIO) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -387,041.00 |
| Jun 30, 2025 | -188,318.00 |
| Dec 31, 2024 | -79,427.00 |
| Jun 30, 2024 | -232,315.00 |
| Sep 30, 2023 | -834,222.00 |
| Mar 31, 2022 | 998,805.00 |
| Sep 30, 2021 | -1.05 Mn |
| Jun 30, 2021 | -93,571.00 |
| Mar 31, 2021 | -44,692.00 |
| Dec 31, 2020 | -8,742.00 |
| Sep 30, 2020 | -110,971.00 |
| Jun 30, 2020 | -3,599.00 |
| Mar 31, 2020 | -363,597.00 |
| Dec 31, 2019 | -70,622.00 |
| Sep 30, 2019 | -204,629.00 |
| Jun 30, 2019 | -23,691.00 |
| Jun 30, 2018 | -380,494.00 |
| Sep 30, 2017 | -222,087.00 |
| Jun 30, 2017 | 22,532.00 |
| Mar 31, 2017 | -1.22 Mn |